Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Pfizer Announces New Chief Business Innovation Officer Aamir Malik
Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive […]
Genomics England Announces Appointment of New Chief Scientific Officer
Genomics England today announces the appointment of Professor Matt Brown as the organisation’s new Chief Scientific Officer […]
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated […]
Mirum Pharmaceuticals Appoints Biotechnology Executive William C. Fairey to its Board of Directors
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the appointment of industry veteran William C. Fairey […]
Aristea Appoints Justin Thacker as Chief Financial Officer
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]
Optimize Health Expands Leadership Team With Three New Executive Hires
Optimize Health, a leader in Remote Patient Monitoring (RPM), today announced it has expanded its […]
ViroCell Announces New Board Appointments
ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, today […]
Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units
Eli Lilly and Company (NYSE: LLY) today announced executive leadership changes and the creation of neuroscience […]
ConcertAI Names Catherine Richards as its First Chief Data Officer and RWD Products Head
ConcertAI, LLC (ConcertAI), a market leader for real-world data (RWD) and enterprise AI technology solutions […]
GeneQuantum Announces a Key Leadership Appointment
GeneQuantum Healthcare, an industry leading biopharmacetucial company dedicated to next generation bioconjugate drugs through innovative […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more